Proving Causation in Delayed Cancer Diagnosis Cases (Loss of Chance)

By John Mahoney · May 2026 · 12 min read

Delayed cancer diagnosis cases are deceptively hard. The breach is often obvious — a missed finding on imaging, a result that was never followed up, a symptom dismissed. What is hard is causation. The defense rarely contests that the diagnosis was delayed. It contests whether the delay changed anything: the patient had cancer either way, and the defense argues the outcome would have been the same regardless of when it was caught.

That argument is what the loss-of-chance doctrine exists to answer. This guide walks through the causation framework for failure-to-diagnose cancer cases — what the doctrine does, how staging progression supplies the proof, and how to structure the expert testimony that connects the delay to a worse outcome.

Disclaimer: This article is informational and not legal advice. The loss-of-chance doctrine is recognized in some jurisdictions and rejected or limited in others, and the measure of damages varies considerably. Confirm whether and how your jurisdiction recognizes loss of chance before building a case on it.

The Traditional Causation Problem

Under a traditional "but-for" causation standard, the plaintiff must show that the negligent delay more likely than not caused the harm. In a cancer case, that can be brutal. If a patient's realistic chance of cure at the time of the missed diagnosis was already below fifty percent, a strict but-for analysis says the patient would probably have had the bad outcome anyway — and the defense will argue the case fails on causation regardless of how clear the negligence was.

The doctrine treats this as unjust: a defendant whose negligence destroyed a real, substantial chance of a better outcome should not escape liability simply because that chance was under fifty percent to begin with. The loss-of-chance framework reconceives the injury as the lost chance itself, not solely the ultimate death or progression.

What Loss of Chance Actually Requires

Jurisdictions that recognize loss of chance generally require the plaintiff to establish, through expert testimony, two things:

1. The chance the patient had at the time of the negligence. What was the realistic probability of a materially better outcome — cure, longer survival, less aggressive treatment — had the diagnosis been made when it should have been?
2. The chance the patient had once the diagnosis was actually made. By the time the cancer was caught, that probability had fallen. The difference between the two is the lost chance the negligence caused.

The measure of damages, where loss of chance is recognized, is frequently tied to that difference rather than to the full value of the ultimate harm. But the doctrine and its damages calculus differ sharply across jurisdictions — some recognize it broadly, some only for wrongful death, some not at all. The threshold question in every such case is whether your venue's law supports the theory.

Staging Progression Is the Engine of Proof

Cancer is unusually well-suited to loss-of-chance proof because oncology stages disease in defined, prognostically meaningful categories. The core of the causation case is showing that the cancer progressed from a more treatable stage to a less treatable one during the period of negligent delay.

The proof structure typically looks like this:

• Establish the stage at the time of the breach. What did the imaging, labs, or symptoms at the missed-diagnosis point indicate about the extent of disease? An oncology or radiology expert reconstructs the probable stage from the contemporaneous record.
• Establish the stage at actual diagnosis. When the cancer was finally caught, what stage was documented?
• Tie stage to prognosis. The expert connects each stage to its associated prognosis using the established medical literature on outcomes by stage — without inventing specific survival percentages that are not supported by an authority the expert can name.
• Attribute the progression to the delay. The expert must connect the stage change to the elapsed time, addressing the natural history of the specific cancer type.

The defense will attack the stage-at-breach reconstruction hardest, because it is the most inferential step. The stronger the contemporaneous record — the imaging that was misread, the result that was never acted on — the more defensible the reconstruction.

The Documentary Spine: The Diagnostic Timeline

Every delayed-diagnosis case rests on a precise timeline of who knew what, when. The load-bearing entries are usually:

Because timing is the whole case, the chronology underlying it has to be defensible — every entry sourced to its page, every date honest about whether it reflects when something was documented or when it occurred. See our guide on building a chronology that survives cross-examination; in a cancer-delay case, that discipline is not optional.

The Expert Architecture

These cases usually require coordinated experts, each carrying a defined piece of the causation chain:

• Standard-of-care expert — establishes that the finding should have been recognized and worked up when it presented.
• Radiology or pathology expert (where applicable) — establishes that the finding was present and detectable in the contemporaneous imaging or specimen.
• Oncology expert — reconstructs the probable stage at the breach, connects stage to prognosis using nameable literature, and attributes the progression to the delay.

Each opinion must show its work in the way the amended reliability standards now demand — method named, applied to these facts, conclusion held to what the method supports. Our piece on bulletproofing the expert report under FRE 702 applies directly: a loss-of-chance opinion that asserts a probability without showing the staging-and-literature reasoning behind it is exactly the kind of ipse dixit that draws a gatekeeping motion.

Common Defense Themes

The cancer was already incurable

The defense argues the disease was advanced or biologically aggressive at the breach point, so earlier diagnosis would not have changed the outcome. The plaintiff response is the stage reconstruction and the natural-history testimony: if the disease was at a meaningfully earlier stage when the finding was missed, the lost chance was real.

The finding was not detectable

The defense argues the missed finding was genuinely occult — not negligently overlooked, but not reasonably detectable at the time. The plaintiff response lives in the contemporaneous record and the standard-of-care expert's read of it.

Loss of chance is not recognized here

In jurisdictions that reject or limit the doctrine, the defense moves to confine the plaintiff to traditional but-for causation. This is why the venue's law is the first thing to confirm — the entire theory of recovery may depend on it.

Bottom Line

Delayed cancer diagnosis cases live and die on causation, not breach. The loss-of-chance doctrine, where recognized, reframes the injury as the destroyed opportunity for a better outcome — and oncology's stage-based prognosis system supplies an unusually concrete way to prove it. The work is reconstructing the diagnostic timeline precisely, establishing the stage at the breach point, and building expert opinions that connect each step without overreaching past what the literature supports.

The foundation is the timeline, and assembling it across years of fragmented records — the index visit, the buried abnormal result, the referral that was never closed — is the slow part. AI-assisted extraction surfaces those load-bearing entries fast, so your experts can spend their time on the staging analysis that actually wins the case.

Questions? Contact us at [email protected] or (856) 979-6525